Hepatitis C virus RNA replication is regulated by Ras-Erk signalling

Journal of General Virology

Volumn 91, Issue 3, 2010, Pages 671-680

  Gretton, Sarah ^a   Hughes, Mair ^a   Harris, Mark ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 (2 CHLORO 4 IODOANILINO) N CYCLOPROPYLMETHOXY 3,4 DIFLUOROBENZAMIDE; CYCLOOXYGENASE 2; LUCIFERASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; NONSTRUCTURAL PROTEIN 5A; PLASMID DNA; RAS PROTEIN; VIRUS RNA;

ARTICLE; CONTROLLED STUDY; ELECTROPORATION; ENZYME INHIBITION; GENETIC TRANSFECTION; GENOTYPE; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REPLICON; RNA REPLICATION; RNA STABILITY; SIGNAL TRANSDUCTION; VIRUS MUTANT; WESTERN BLOTTING;

BENZAMIDES; BUTADIENES; ENZYME INHIBITORS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLAVONOIDS; HEPACIVIRUS; MAP KINASE KINASE 1; NITRILES; RAS GTPASE-ACTIVATING PROTEINS; RNA, VIRAL; SIGNAL TRANSDUCTION; VIRUS REPLICATION;

HEPATITIS C VIRUS;

EID: 76849092904     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.016899-0     Document Type: Article

References (28)

1. Appel, N., Pietschmann, T. & Bartenschlager, R. (2005). Mutational analysis of hepatitis C virus nonstructural protein 5A: potential role of differential phosphorylation in RNA replication and identification of a genetically flexible domain. J Virol 79, 3187-3194.
2. Bain, J., Plater, L., Elliott, M., Shpiro, N., Hastie, C. J., McLauchlan, H., Klevernic, I., Arthur, J. S., Alessi, D. R. & Cohen, P. (2007). The selectivity of protein kinase inhibitors: a further update. Biochem J 408, 297-315.
3. Blight, K. J., McKeating, J. A. & Rice, C. M. (2002). Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J Virol 76, 13001-13014.
4. Borsch-Haubold, A. G., Pasquet, S. & Watson, S. P. (1998). Direct inhibition of cyclooxygenase-1 and -2 by the kinase inhibitors SB 203580 and PD 98059. SB 203580 also inhibits thromboxane synthase. J Biol Chem 273, 28766-28772.
5. Coito, C., Diamond, D. L., Neddermann, P., Korth, M. J. & Katze, M. G. (2004). High-throughput screening of the yeast kinome: identification of human serine/threonine protein kinases that phosphorylate the hepatitis C virus NS5A protein. J Virol 78, 3502-3513.
6. Cowley, S., Paterson, H., Kemp, P. & Marshall, C. J. (1994). Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 77, 841-852.
7. Davies, S. P., Reddy, H., Caivano, M. & Cohen, P. (2000). Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351, 95-105.
8. Favata, M. F., Horiuchi, K. Y., Manos, E. J., Daulerio, A. J., Stradley, D. A., Feeser, W. S., Van Dyk, D. E., Pitts, W. J., Earl, R. A. & other authors (1998). Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem 273, 18623-18632.
9. Georgopoulou, U., Caravokiri, K. & Mavromara, P. (2003). Suppression of the ERK1/2 signaling pathway from HCV NS5A protein expressed by herpes simplex recombinant viruses. Arch Virol 148, 237-251.
10. Huang, Y., Chen, X. C., Konduri, M., Fomina, N., Lu, J., Jin, L., Kolykhalov, A. & Tan, S. L. (2006). Mechanistic link between the anti-HCV effect of interferon gamma and control of viral replication by a Ras-MAPK signaling cascade. Hepatology 43, 81-90.
11. Hughes, M., Gretton, S., Shelton, H., Brown, D. D., McCormick, C. J., Angus, A. G., Patel, A. H., Griffin, S. & Harris, M. (2009). A conserved proline between domains II and III of hepatitis C virus NS5A influences both RNA replication and virus assembly. J Virol 83, 10788-10796.
12. Krieger, N., Lohmann, V. & Bartenschlager, R. (2001). Enhancement of hepatitis C virus RNA replication by cell culture-adaptive mutations. J Virol 75, 4614-4624.
13. Lohmann, V., Korner, F., Koch, J., Herian, U., Theilmann, L. & Bartenschlager, R. (1999). Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285, 110-113.
14. Macdonald, A. & Harris, M. (2004). Hepatitis C virus NS5A: tales of a promiscuous protein. J Gen Virol 85, 2485-2502.
15. Macdonald, A., Crowder, K., Street, A., McCormick, C., Saksela, K. & Harris, M. (2003). The hepatitis C virus non-structural NS5A protein inhibits activating P-protein-1 function by perturbing Ras-ERK pathway signaling. J Biol Chem 278, 17775-17784.
16. Macdonald, A., Chan, J. K. & Harris, M. (2005a). Perturbation of epidermal growth factor receptor complex formation and Ras signalling in cells harbouring the hepatitis C virus subgenomic replicon. J Gen Virol 86, 1027-1033.
17. Macdonald, A., Mazaleyrat, S., McCormick, C., Street, A., Burgoyne, N. J., Jackson, R. M., Cazeaux, V., Shelton, H., Saksela, K. & Harris, M. (2005b). Further studies on hepatitis C virus NS5A-SH3 domain interactions: identification of residues critical for binding and implications for viral RNA replication and modulation of cell signalling. J Gen Virol 86, 1035-1044.
18. Mankouri, J., Griffin, S. & Harris, M. (2008). The hepatitis C virus non-structural protein NS5A alters the trafficking profile of the epidermal growth factor receptor. Traffic 9, 1497-1509.
19. Murata, T., Hijikata, M. & Shimotohno, K. (2005). Enhancement of internal ribosome entry site-mediated translation and replication of hepatitis C virus by PD98059. Virology 340, 105-115.
20. Nanda, S. K., Herion, D. & Liang, T. J. (2006). The SH3 binding motif of HCV NS5A protein interacts with Bin1 and is important for apoptosis and infectivity. Gastroenterology 130, 794-809.
21. Neddermann, P., Quintavalle, M., Di Pietro, C., Clementi, A., Cerretani, M., Altamura, S., Bartholomew, L. & De Francesco, R. (2004). Reduction of hepatitis C virus NS5A hyperphosphorylation by selective inhibition of cellular kinases activates viral RNA replication in cell culture. J Virol 78, 13306-13314.
22. Sarfraz, S., Hamid, S., Siddiqui, A., Hussain, S., Pervez, S. & Alexander, G. (2008). Altered expression of cell cycle and apoptotic proteins in chronic hepatitis C virus infection. BMC Microbiol 8, 133.
23. Scholle, F., Li, K., Bodola, F., Ikeda, M., Luxon, B. A. & Lemon, S. M. (2004). Virus-host cell interactions during hepatitis C virus RNA replication: impact of polyprotein expression on the cellular transcriptome and cell cycle association with viral RNA synthesis. J Virol 78, 1513-1524.
24. Tan, S. L., Nakao, H., He, Y., Vijaysri, S., Neddermann, P., Jacobs, B. L., Mayer, B. J. & Katze, M. G. (1999). NS5A, a nonstructural protein of hepatitis C virus, binds growth factor receptor-bound protein 2 adaptor protein in a Src homology 3 domain/liganddependent manner and perturbs mitogenic signaling. Proc Natl Acad Sci U S A 96, 5533-5538.
25. Targett-Adams, P. & McLauchlan, J. (2005). Development and characterization of a transient-replication assay for the genotype 2a hepatitis C virus subgenomic replicon. J Gen Virol 86, 3075-3080.
26. Trujillo-Murillo, K., Rincon-Sanchez, A. R., Martinez-Rodriguez, H., Bosques-Padilla, F., Ramos-Jimenez, J., Barrera-Saldana, H. A., Rojkind, M. & Rivas-Estilla, A. M. (2008). Acetylsalicylic acid inhibits hepatitis C virus RNA and protein expression through cyclooxygenase 2 signaling pathways. Hepatology 47, 1462-1472.
27. Waris, G. & Siddiqui, A. (2005). Hepatitis C virus stimulates the expression of cyclooxygenase-2 via oxidative stress: role of prostaglandin E2 in RNA replication. J Virol 79, 9725-9734.
28. Zhu, H. & Liu, C. (2003). Interleukin-1 inhibits hepatitis C virus subgenomic RNA replication by activation of extracellular regulated kinase pathway. J Virol 77, 5493-5498.